Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Aoki, Shin"" wg kryterium: Autor


Tytuł:
Development of Wireless Power-Transmission-Based Photodynamic Therapy for the Induction of Cell Death in Cancer Cells by Cyclometalated Iridium(III) Complexes.
Autorzy:
Yokoi, Kenta
Yasuda, Yoshitaka
Kanbe, Azusa
Imura, Takehiro
Aoki, Shin
Pokaż więcej
Temat:
CELL death
PHOTODYNAMIC therapy
CANCER cells
PHOSPHORESCENCE
WIRELESS power transmission
IRIDIUM
CELLULAR therapy
Źródło:
Molecules; Feb2023, Vol. 28 Issue 3, p1433, 14p
Czasopismo naukowe
Tytuł:
Profiling Differential Effects of 5 Selective Serotonin Reuptake Inhibitors on TLRs-Dependent and -Independent IL-6 Production in Immune Cells Identifies Fluoxetine as Preferred Anti-Inflammatory Drug Candidate.
Autorzy:
Takenaka, Yohei
Tanaka, Ryu
Kitabatake, Kazuki
Kuramochi, Kouji
Aoki, Shin
Tsukimoto, Mitsutoshi
Pokaż więcej
Temat:
SEROTONIN uptake inhibitors
ANTIDEPRESSANTS
ANTI-inflammatory agents
CONCANAVALIN A
INTERLEUKIN-6
FLUOXETINE
T cells
Źródło:
Frontiers in Pharmacology; 6/22/2022, Vol. 13, p1-18, 18p
Przedsiębiorstwo/ jednostka:
UNITED States. Food & Drug Administration
Czasopismo naukowe
Tytuł:
Design and synthesis of spirooxindole–pyrrolidines embedded with indole and pyridine heterocycles by multicomponent reaction: anticancer and in silico studies.
Autorzy:
Mayakrishnan, Sivakalai
Kathirvelan, Devarajan
Arun, Yuvaraj
Saranraj, Krishnan
Balachandran, Chandrasekaran
Aoki, Shin
Yuvaraj, Pannerselvam
Maheswarai, Narayanan Uma
Pokaż więcej
Temat:
INDOLE
HETEROCYCLIC compounds
DRUG discovery
PYRIDINE
PHARMACEUTICAL chemistry
SCHIFF bases
IMIDAZOPYRIDINES
Źródło:
New Journal of Chemistry; 6/7/2022, Vol. 46 Issue 21, p10089-10106, 18p
Czasopismo naukowe
Tytuł:
Design, Synthesis and Biological Evaluation of Boron‐Containing Macrocyclic Polyamine Dimers and Their Zinc(II) Complexes for Boron Neutron Capture Therapy.
Autorzy:
Ueda, Hiroki
Suzuki, Minoru
Sakurai, Yoshinori
Tanaka, Tomohiro
Aoki, Shin
Pokaż więcej
Temat:
BORON-neutron capture therapy
BIOSYNTHESIS
NEUTRON capture
ZINC powder
MACROCYCLIC compounds
DIMERS
THERMAL neutrons
NEUTRON irradiation
Źródło:
European Journal of Inorganic Chemistry; 2/16/2022, Vol. 2022 Issue 5, p1-24, 24p
Czasopismo naukowe
Tytuł:
Evaluation of sodium orthovanadate as a radioprotective agent under total-body irradiation and partial-body irradiation conditions in mice.
Autorzy:
Nishiyama, Yuichi
Morita, Akinori
Wang, Bing
Sakai, Takuma
Ramadhani, Dwi
Satoh, Hidetoshi
Tanaka, Kaoru
Sasatani, Megumi
Ochi, Shintaro
Tominaga, Masahide
Ikushima, Hitoshi
Ueno, Junji
Nenoi, Mitsuru
Aoki, Shin
Pokaż więcej
Temat:
RADIATION-protective agents
SURVIVAL rate
LABORATORY mice
IRRADIATION
RADIATION injuries
SODIUM orthovanadate
HEMATOPOIETIC system
GASTROINTESTINAL system
Źródło:
International Journal of Radiation Biology; 2021, Vol. 97 Issue 9, p1241-1251, 11p
Czasopismo naukowe
Tytuł:
Impact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients with type 2 diabetes treated with canagliflozin plus teneligliptin.
Autorzy:
Miya, Aika
Nakamura, Akinobu
Cho, Kyu Yong
Kawata, Shinichiro
Nomoto, Hiroshi
Nagai, So
Sugawara, Hajime
Taneda, Shinji
Tsuchida, Kazuhisa
Omori, Kazuno
Yokoyama, Hiroki
Takeuchi, Jun
Aoki, Shin
Kurihara, Yoshio
Atsumi, Tatsuya
Miyoshi, Hideaki
Pokaż więcej
Temat:
SODIUM-glucose cotransporter 2 inhibitors
TYPE 2 diabetes
CANAGLIFLOZIN
JAPANESE people
INSULIN
Źródło:
Journal of Diabetes Investigation; Aug2021, Vol. 12 Issue 8, p1395-1399, 5p
Czasopismo naukowe
Tytuł:
Favorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone.
Autorzy:
Cho, Kyu Yong
Nakamura, Akinobu
Omori, Kazuno
Takase, Takahiro
Miya, Aika
Yamamoto, Kohei
Nomoto, Hiroshi
Kameda, Hiraku
Taneda, Shinji
Kurihara, Yoshio
Aoki, Shin
Atsumi, Tatsuya
Miyoshi, Hideaki
Pokaż więcej
Temat:
DAPAGLIFLOZIN
SODIUM-glucose cotransporter 2 inhibitors
NON-alcoholic fatty liver disease
PIOGLITAZONE
FATTY liver
GLYCOSYLATED hemoglobin
Źródło:
Journal of Diabetes Investigation; Jul2021, Vol. 12 Issue 7, p1272-1277, 6p
Czasopismo naukowe
Tytuł:
Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro.
Autorzy:
Shionoya, Kaho
Yamasaki, Masako
Iwanami, Shoya
Ito, Yusuke
Fukushi, Shuetsu
Ohashi, Hirofumi
Saso, Wakana
Tanaka, Tomohiro
Aoki, Shin
Kuramochi, Kouji
Iwami, Shingo
Takahashi, Yoshimasa
Suzuki, Tadaki
Muramatsu, Masamichi
Takeda, Makoto
Wakita, Takaji
Watashi, Koichi
Pokaż więcej
Temat:
COVID-19
SARS-CoV-2
MEFLOQUINE
ANTIVIRAL agents
ANTIPARASITIC agents
HYDROXYCHLOROQUINE
VIRAL load
Źródło:
Frontiers in Microbiology; 4/30/2021, Vol. 11, pN.PAG-N.PAG, 12p
Czasopismo naukowe
Tytuł:
Effects of Switching from Liraglutide or Dulaglutide to Subcutaneous Semaglutide on Glucose Metabolism and Treatment Satisfaction in Patients with Type 2 Diabetes: Protocol for a Multicenter, Prospective, Randomized, Open-Label, Blinded-Endpoint, Parallel-Group Comparison Study (The SWITCH-SEMA 1 Study)
Autorzy:
Nomoto, Hiroshi
Oba-Yamamoto, Chiho
Takahashi, Yuka
Takeuchi, Jun
Nagai, So
Yokoyama, Hiroki
Taneda, Shinji
Kurihara, Yoshio
Aoki, Shin
Kameda, Hiraku
Cho, Kyu Yong
Nakamura, Akinobu
Atsumi, Tatsuya
Miyoshi, Hideaki
Pokaż więcej
Temat:
PATIENT satisfaction
TYPE 2 diabetes
LIRAGLUTIDE
GLUCOSE metabolism
GLUCAGON-like peptide-1 agonists
SEMAGLUTIDE
Źródło:
Diabetes Therapy; Mar2021, Vol. 12 Issue 3, p955-964, 10p
Przedsiębiorstwo/ jednostka:
UNIVERSITY of Colorado Hospital
Czasopismo naukowe
Tytuł:
Sodium–glucose cotransporter 2 inhibitors reduce day‐to‐day glucose variability in patients with type 1 diabetes.
Autorzy:
Chiba, Koki
Nomoto, Hiroshi
Nakamura, Akinobu
Cho, Kyu Yong
Yamashita, Kumiko
Shibayama, Yui
Miya, Aika
Kameda, Hiraku
Kurihara, Yoshio
Aoki, Shin
Atsumi, Tatsuya
Miyoshi, Hideaki
Pokaż więcej
Temat:
SODIUM-glucose cotransporter 2 inhibitors
TYPE 1 diabetes
GLUCOSE
GLYCOSYLATED hemoglobin
DRUG efficacy
Źródło:
Journal of Diabetes Investigation; Feb2021, Vol. 12 Issue 2, p176-183, 8p
Czasopismo naukowe
Tytuł:
Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial.
Autorzy:
Kyu Yong Cho
Nakamura, Akinobu
Chiho Oba-Yamamoto
Kazuhisa Tsuchida
Shingo Yanagiya
Naoki Manda
Yoshio Kurihara
Aoki, Shin
Atsumi, Tatsuya
Hideaki Miyoshi
Pokaż więcej
Temat:
INSULIN aspart
TYPE 2 diabetes
RANDOMIZED controlled trials
INSULIN
INSULIN pumps
GLYCOSYLATED hemoglobin
Źródło:
Diabetes & Metabolism Journal; Aug2020, Vol. 44 Issue 4, p532-541, 11p
Czasopismo naukowe
Tytuł:
ROS-Responsive Chitosan Coated Magnetic Iron Oxide Nanoparticles as Potential Vehicles for Targeted Drug Delivery in Cancer Therapy.
Autorzy:
Ayyanaar, Srinivasan
Balachandran, Chandrasekar
Bhaskar, Rangaswamy Chinnabba
Kesavan, Mookkandi Palsamy
Aoki, Shin
Raja, Ramachandran Palpandi
Rajesh, Jegathalaprathaban
Webster, Thomas J
Rajagopal, Gurusamy
Pokaż więcej
Źródło:
International Journal of Nanomedicine; May2020, Vol. 15, p3333-3346, 14p
Czasopismo naukowe
Tytuł:
Favourable effect of the sodium‐glucose co‐transporter‐2 inhibitor canagliflozin plus the dipeptidyl peptidase‐4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open‐label, prospective, randomized, parallel‐group comparison trial (the CALMER study)
Autorzy:
Cho, Kyu Yong
Nomoto, Hiroshi
Nakamura, Akinobu
Kawata, Shinichiro
Sugawara, Hajime
Takeuchi, Jun
Nagai, So
Tsuchida, Kazuhisa
Omori, Kazuno
Yokoyama, Hiroki
Manda, Naoki
Kurihara, Yoshio
Aoki, Shin
Atsumi, Tatsuya
Miyoshi, Hideaki
Pokaż więcej
Temat:
SODIUM-glucose cotransporters
CANAGLIFLOZIN
TYPE 2 diabetes
BLOOD sugar
GLYCEMIC index
Źródło:
Diabetes, Obesity & Metabolism; Mar2020, Vol. 22 Issue 3, p458-462, 5p
Czasopismo naukowe
Tytuł:
Evaluation of Zn Complexes Based on Shape Measurement Factors: Relationships between Activity and the Coordination Structure.
Autorzy:
Aoki, Shin
Kikuchi, Chiharu
Kitagawa, Yuichi
Hasegawa, Yasuchika
Sonoike, Shotaro
Saga, Yutaka
Hatanaka, Miho
Pokaż więcej
Temat:
SHAPE measurement
ALDOLS
ASYMMETRIC synthesis
KETONE derivatives
ALDOLASES
CATALYTIC activity
Źródło:
European Journal of Inorganic Chemistry; 11/30/2019, Vol. 2019 Issue 44, p4740-4751, 12p
Czasopismo naukowe
Tytuł:
The design and green synthesis of novel benzotriazoloquinolinyl spirooxindolopyrrolizidines: antimycobacterial and antiproliferative studies.
Autorzy:
Pogaku, Vinay
Krishna, Vagolu Siva
Balachandran, Chandrasekar
Rangan, Krishnan
Sriram, Dharmarajan
Aoki, Shin
Basavoju, Srinivas
Pokaż więcej
Temat:
SUSTAINABLE design
CELL death inhibition
ETHAMBUTOL
DRUG standards
CELL lines
Źródło:
New Journal of Chemistry; 11/28/2019, Vol. 43 Issue 44, p17511-17520, 10p
Czasopismo naukowe
Tytuł:
NHC-catalyzed green synthesis of functionalized chromones: DFT mechanistic insights and in vitro activities in cancer cells.
Autorzy:
Murugesh, Nithya
Haribabu, Jebiti
Arumugam, Krishnamoorthy
Balachandran, Chandrasekar
Swaathy, Rajagopal
Aoki, Shin
Sreekanth, Anandaram
Karvembu, Ramasamy
Vedachalam, Seenuvasan
Pokaż więcej
Temat:
CANCER cells
CHROMONES
SMALL molecules
HELA cells
CARBON-carbon bonds
CYANIDES
Źródło:
New Journal of Chemistry; 9/14/2019, Vol. 43 Issue 34, p13509-13525, 17p
Czasopismo naukowe
Tytuł:
Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial.
Autorzy:
Takase, Takahiro
Nakamura, Akinobu
Yamamoto, Chiho
Nomoto, Hiroshi
Miya, Aika
Dannoura, Midori
Cho, Kyu Yong
Kurihara, Yoshio
Manda, Naoki
Aoki, Shin
Atsumi, Tatsuya
Miyoshi, Hideaki
Pokaż więcej
Temat:
TYPE 2 diabetes
GLUCAGON-like peptide-1 receptor
RANDOMIZED controlled trials
GLUCAGON-like peptide-1 agonists
THERAPEUTICS
LIRAGLUTIDE
Źródło:
Journal of Diabetes Investigation; May2019, Vol. 10 Issue 3, p699-705, 7p
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies